Antihypertensive prescriptions for newly treated patients before and after the Main Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial results and Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure guidelines

Paul Muntner, Marie Krousel-Wood, Amanda D. Hyre, Erin Stanley, William Cushman, Jeffrey A. Cutler, Linda B. Piller, Gary A. Goforth, Paul K. Whelton

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Main results of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial were published in December 2002. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, published in May 2003, recommended thiazide-type diuretics as initial pharmacological treatment alone or in combination with another drug in most patients with hypertension. To assess changes from before to after these publications, we compared antihypertensive medication prescriptions filled by patients who initiated pharmacological antihypertensive treatment in a large managed care organization during 3 time periods: (1) July 1, 2001, to June 30, 2002 (before these publications; n=1354); (2) July 1, 2003, to June 30, 2004 (to assess short-term changes; n= 1542); and (3) July 1, 2004, to June 30, 2005 (to assess extended changes; n= 1865). The percentage of patients initiating antihypertensive treatment with a thiazide-type diuretic increased from 30.6% to 39.4% (P<0.001) between 2001-2002 and 2003-2004, and the increase was maintained at 36.5% in 2004-2005 (P<0.001 compared with 2001-2002 and P=0.33 compared with 2003-2004). Among patients without diabetes mellitus, renal disease, a history of myocardial infarction, or heart failure, the percentage initiating pharmacological antihypertensive treatment with a thiazide-type diuretic increased from 33.1% in 2001-2002 to 43.4% in 2003-2004 (P<0.001) and remained increased (41.0%) in 2004-2005 (P<0.001 and P=0.23 compared with 2001-2002 and 2003-2004, respectively). Despite a sustained increase in the use of thiazide-type diuretics, this study indicates that an opportunity exists to increase adherence to the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure guidelines. (Hypertension. 2009;53:617-623.)

Original languageEnglish (US)
Pages (from-to)617-623
Number of pages7
JournalHypertension
Volume53
Issue number4
DOIs
StatePublished - Apr 1 2009
Externally publishedYes

Fingerprint

Antihypertensive Agents
Prescriptions
Sodium Chloride Symporter Inhibitors
Myocardial Infarction
Guidelines
Hypertension
Lipids
Pharmacology
Therapeutics
Publications
Heart Failure
Managed Care Programs
Diabetes Mellitus
Kidney
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

Antihypertensive prescriptions for newly treated patients before and after the Main Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial results and Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure guidelines. / Muntner, Paul; Krousel-Wood, Marie; Hyre, Amanda D.; Stanley, Erin; Cushman, William; Cutler, Jeffrey A.; Piller, Linda B.; Goforth, Gary A.; Whelton, Paul K.

In: Hypertension, Vol. 53, No. 4, 01.04.2009, p. 617-623.

Research output: Contribution to journalArticle

@article{feec93ca63d949549d991d87fee49402,
title = "Antihypertensive prescriptions for newly treated patients before and after the Main Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial results and Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure guidelines",
abstract = "Main results of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial were published in December 2002. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, published in May 2003, recommended thiazide-type diuretics as initial pharmacological treatment alone or in combination with another drug in most patients with hypertension. To assess changes from before to after these publications, we compared antihypertensive medication prescriptions filled by patients who initiated pharmacological antihypertensive treatment in a large managed care organization during 3 time periods: (1) July 1, 2001, to June 30, 2002 (before these publications; n=1354); (2) July 1, 2003, to June 30, 2004 (to assess short-term changes; n= 1542); and (3) July 1, 2004, to June 30, 2005 (to assess extended changes; n= 1865). The percentage of patients initiating antihypertensive treatment with a thiazide-type diuretic increased from 30.6{\%} to 39.4{\%} (P<0.001) between 2001-2002 and 2003-2004, and the increase was maintained at 36.5{\%} in 2004-2005 (P<0.001 compared with 2001-2002 and P=0.33 compared with 2003-2004). Among patients without diabetes mellitus, renal disease, a history of myocardial infarction, or heart failure, the percentage initiating pharmacological antihypertensive treatment with a thiazide-type diuretic increased from 33.1{\%} in 2001-2002 to 43.4{\%} in 2003-2004 (P<0.001) and remained increased (41.0{\%}) in 2004-2005 (P<0.001 and P=0.23 compared with 2001-2002 and 2003-2004, respectively). Despite a sustained increase in the use of thiazide-type diuretics, this study indicates that an opportunity exists to increase adherence to the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure guidelines. (Hypertension. 2009;53:617-623.)",
author = "Paul Muntner and Marie Krousel-Wood and Hyre, {Amanda D.} and Erin Stanley and William Cushman and Cutler, {Jeffrey A.} and Piller, {Linda B.} and Goforth, {Gary A.} and Whelton, {Paul K.}",
year = "2009",
month = "4",
day = "1",
doi = "10.1161/HYPERTENSIONAHA.108.120154",
language = "English (US)",
volume = "53",
pages = "617--623",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Antihypertensive prescriptions for newly treated patients before and after the Main Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial results and Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure guidelines

AU - Muntner, Paul

AU - Krousel-Wood, Marie

AU - Hyre, Amanda D.

AU - Stanley, Erin

AU - Cushman, William

AU - Cutler, Jeffrey A.

AU - Piller, Linda B.

AU - Goforth, Gary A.

AU - Whelton, Paul K.

PY - 2009/4/1

Y1 - 2009/4/1

N2 - Main results of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial were published in December 2002. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, published in May 2003, recommended thiazide-type diuretics as initial pharmacological treatment alone or in combination with another drug in most patients with hypertension. To assess changes from before to after these publications, we compared antihypertensive medication prescriptions filled by patients who initiated pharmacological antihypertensive treatment in a large managed care organization during 3 time periods: (1) July 1, 2001, to June 30, 2002 (before these publications; n=1354); (2) July 1, 2003, to June 30, 2004 (to assess short-term changes; n= 1542); and (3) July 1, 2004, to June 30, 2005 (to assess extended changes; n= 1865). The percentage of patients initiating antihypertensive treatment with a thiazide-type diuretic increased from 30.6% to 39.4% (P<0.001) between 2001-2002 and 2003-2004, and the increase was maintained at 36.5% in 2004-2005 (P<0.001 compared with 2001-2002 and P=0.33 compared with 2003-2004). Among patients without diabetes mellitus, renal disease, a history of myocardial infarction, or heart failure, the percentage initiating pharmacological antihypertensive treatment with a thiazide-type diuretic increased from 33.1% in 2001-2002 to 43.4% in 2003-2004 (P<0.001) and remained increased (41.0%) in 2004-2005 (P<0.001 and P=0.23 compared with 2001-2002 and 2003-2004, respectively). Despite a sustained increase in the use of thiazide-type diuretics, this study indicates that an opportunity exists to increase adherence to the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure guidelines. (Hypertension. 2009;53:617-623.)

AB - Main results of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial were published in December 2002. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, published in May 2003, recommended thiazide-type diuretics as initial pharmacological treatment alone or in combination with another drug in most patients with hypertension. To assess changes from before to after these publications, we compared antihypertensive medication prescriptions filled by patients who initiated pharmacological antihypertensive treatment in a large managed care organization during 3 time periods: (1) July 1, 2001, to June 30, 2002 (before these publications; n=1354); (2) July 1, 2003, to June 30, 2004 (to assess short-term changes; n= 1542); and (3) July 1, 2004, to June 30, 2005 (to assess extended changes; n= 1865). The percentage of patients initiating antihypertensive treatment with a thiazide-type diuretic increased from 30.6% to 39.4% (P<0.001) between 2001-2002 and 2003-2004, and the increase was maintained at 36.5% in 2004-2005 (P<0.001 compared with 2001-2002 and P=0.33 compared with 2003-2004). Among patients without diabetes mellitus, renal disease, a history of myocardial infarction, or heart failure, the percentage initiating pharmacological antihypertensive treatment with a thiazide-type diuretic increased from 33.1% in 2001-2002 to 43.4% in 2003-2004 (P<0.001) and remained increased (41.0%) in 2004-2005 (P<0.001 and P=0.23 compared with 2001-2002 and 2003-2004, respectively). Despite a sustained increase in the use of thiazide-type diuretics, this study indicates that an opportunity exists to increase adherence to the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure guidelines. (Hypertension. 2009;53:617-623.)

UR - http://www.scopus.com/inward/record.url?scp=64849103122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64849103122&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.108.120154

DO - 10.1161/HYPERTENSIONAHA.108.120154

M3 - Article

VL - 53

SP - 617

EP - 623

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 4

ER -